Keith Laws, professor of Cognitive Neuropsychology, University of Hertfordshire in The Conversation: Why CBT should stop being offered to people with schizophrenia Cognitive behavioural therapy, or CBT, has in the past decade become a standard tool for helping people with schizophrenia deal with their symptoms. Recent developments, however, raise serious questions about how effective this talking therapy really is for this illness. Despite strongly advocating that all people with schizophrenia should be offered CBT, the National Institute for Health and Care Excellence (NICE) – the organisation that evaluates treatments for the NHS – has inexplicably neglected to update its evidence base since 2008. In the intervening years the number of randomised controlled trials – the gold standard for clinical research – assessing symptom reduction through CBT has doubled, and many of them cast doubt on the institute’s recommendations. Very few trials had reported on the impact of CBT on social and professional functionality, or quality of life, so with this in mind we recently published the first meta-analysis assessing the impact of CBT on these aspects. The results were not positive.